Table 1.
Isolates | Age group | PFGE pattern | MIC of colistin (mg/L) | Other resistance phenotypec | Genetic environment | Replicon | Conjugation frequency | Plasmid size (kb) | Other resistance gene (s) |
---|---|---|---|---|---|---|---|---|---|
SHP50 | 50 days | F | 4 | FFC, TET, CIP, SXT | IncI2-mcr-1-IncI2 | IncI2 | 4 × 10−4 | ~60 | oqxAB, floR |
SHP52 | 50 days | G | 4 | AMP, FFC, NEO, TET, CIP | IncX4-mcr-1-IncX4 | IncX4 | 1.27 × 10−3 | ~33 | oqxAB, floR |
SHP49, SHP36 | 50 days | E | 8 | AMP, FFC, GEN, NEO, CIP, SXT | IncX4-mcr-1-IncX4 | IncX4 | 2 × 10−5, 1.78 × 10−4 | ~33 | oqxAB, floR |
SHP47 | 50 days | P | 8 | AMP, CTX, FFC, FOS, GEN, NEO, SXT | ISApI1-mcr-1-IncHI2 | IncHI2 (ST3) | 2 × 10−6 | ~244 | blaCTX−M−14, floR, fosA3, oqxAB |
SHP48 | 50 days | Q | 8 | NEO, FFC, SXT, TET, CIP | ISApI1-mcr-1- IncHI2 | IncHI2 (ST3) | – | ~275 | oqxAB, floR |
SHP39 | 50 days | N | 4 | AMP, CTX, FFC, FOS, GEN, NEO, TET, SXT | ISApI1-mcr-1-IncHI2 | IncHI2 (ST3) | 2 × 10−6 | ~244 | blaCTX−M−14, floR, fosA3, oqxAB |
SHP41 | 50 days | O | 4 | AMP, CTX, FFC, FOS, TET, SXT | ISApI1-mcr-1- ISApI1, IncX4-mcr-1-IncX4 | IncHI2 (ST3), IncX4 | – | ~238, ~33 | blaCTX−M−15, floR, fosA3, oqxAB |
SHP51 | 50 days | R | 8 | AMP, CTX, FFC, FOS, GEN, NEO, TET, SXT | ISApI1-mcr-1-IncHI2, ISApI1-mcr-1- ISApI1 | IncHI2 (ST3) | 2.90 × 10−5 | ~244, chromosome | blaCTX−M−14, floR, fosA3 |
SHP43 | 50 days | D3 | 8 | AMP, CTX, FFC, FOS, GEN, NEO, CIP, SXT | ISApI1-mcr-1-IncHI2 | IncY-IncHI2 | – | ~350 | blaCTX−M−14, floR, fosA3, oqxAB |
SHP45 | 50 days | D2 | 8 | AMP, CTX, FFC, FOS, GEN, NEO, TET, CIP, SXT | ISApI1-mcr-1-IncI2, ISApI1-mcr-1-IncHI2 | IncI2, IncHI2 (ST3) | – | ~64, ~244 | blaCTX−M−14, floR, fosA3, oqxAB |
SHP26 | 70 days | D1 | 8 | AMP, CTX, FFC, FOS, GEN, NEO, TET, CIP, SXT | ISApI1-mcr-1-IncHI2 | IncHI2 (ST3) | 6.84 × 10−5 | ~244 | blaCTX−M−14, floR, fosA3, oqxAB |
SHP46a | 50 days | K2 | 4 | AMP, FFC, NEO, SXT | ISApI1-mcr-1-? | ND | – | ~104 | oqxAB, floR |
SHP22 | 70 days | K1 | 8 | AMP, FFC, NEO, SXT | ISApI1-mcr-1- ISApI1 | F29:A-:B- | – | ~78 | floR |
SHP17 | 70 days | J | 4 | AMP, CTX, FFC, NEO, TET, SXT | unknown | IncY | 8.64 × 10−6 | ~83 | blaCTX−M−55, oqxAB, floR |
SHP28 | 70 days | J | 8 | AMP, CTX, FFC, NEO, TET, SXT | IncX4-mcr-1-IncX4 | IncX4 | – | ~33 | oqxAB, floR |
SHP31a | 70 days | L | 8 | FFC, NEO, TET, CIP, SXT | ISApI1-mcr-1- ISApI1 | ND | – | ~80 | oqxAB, floR |
SHP24 | 70 days | L | 8 | FFC, NEO, TET, SXT | ISApI1-mcr-1- ISApI1 | F53:A-:B- | – | ~80 | floR |
SHP33a | 70 days | M | 16 | FFC, NEO, TET, CIP, SXT | unknown | NA | – | chromosome | oqxAB, floR |
SHP23 | 70 days | smeared | 8 | AMP, FFC, NEO, TET, CIP, SXT | IncX4-mcr-1-IncX4 | IncX4 | 5.43 × 10−5 | ~33 | oqxAB, floR |
SHP32 | 70 days | A | 4 | AMP, FFC, TET, CIP, SXT | IncX4-mcr-1-IncX4 | IncX4 | – | ~33 | oqxAB, floR |
SHP14b | 4 months | A | 8 | AMP, FFC, GEN, TET, CIP, SXT | IncX4-mcr-1-IncX4 | IncX4 | – | ~33 | oqxAB, floR |
SHP16 | 4 months | I | 8 | TET, SXT | ISApI1-mcr-1-IncI2 | IncI2 | 8.12 × 10−5 | ~64 | oqxAB |
SHP10 | 4 months | H | 8 | AMP, FFC, NEO, TET, SXT | IncX4-mcr-1-IncX4 | IncX4 | 5 × 10−6 | ~33 | oqxAB, floR |
SHP8 | 4 months | C | 8 | AMP, FFC, NEO, TET, SXT | ISApI1-mcr-1-IncI2 | IncI2 | – | ~62 | oqxAB, floR |
SHP7 | 4 months | B | 4 | AMP, CTX, FOX, FFC, TET, SXT | IncX4-mcr-1-IncX4, ISApI1-mcr-1-IncI2 | IncX4, IncI2 | – | ~33, ~62 | oqxAB, floR, blaCMY−2 |
SHP59 | 5 months | S | 4 | AMP, FFC, TET, SXT | IncX4-mcr-1-IncX4 | IncX4 | – | ~33 | oqxAB, floR |
Isolates failed to get transconjugants.
Isolates successfully get transformant by the electroporation.
AMP, ampicillin; CIP, ciprofloxacin; CTX, cefotaxime; FFC, florfenicol; FOS, fosfomycin; GEN, gentamicin; NEO, neomycin; SXT, sulfamethoxazole-trimethoprim; TET, tetracycline. Patterns transferred by conjugation are underlined.